The cost effectiveness of imatinib mesylate was estimated by extrapolating long-term survival and costs from the pivotal multicentre trial of 147 patients with advanced GIST receiving imatinib ...

The objective of this study was to estimate the cost effectiveness of imatinib mesylate in the treatment of GIST. Methods: A cost-effectiveness model of GIST treatment was developed. Long- term ...

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “ammunition in the war against cancer.” Along with a picture of the ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

Get detailed information on Imatinib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that ...

The patent loss of its biggest earning drug has hit Novartis’ revenues ... Chronic myeloid leukaemia (CML) blockbuster Gleevec has been badly hit by generic competition in the US, revenues ...

Due to rising medication costs, many patients are forced to abandon their treatments. Additionally, the significant lack of cost-related information continues to limit healthcare workers from ...

Imatinib (Imkeldi) is the first oral liquid TKI approved for multiple cancers, enhancing treatment accessibility and dosing precision. The drug is effective as a first-line treatment, especially ...

Are the out-of-pocket costs of your medications taking a toll on your finances? Rising drug costs are happening to many people with neurological diseases, but people with multiple sclerosis (MS) ...